Dai Wang Selected Research

Dai Wang Research Topics

Disease

39	Infections 12/2023 - 02/2002
6	Virus Diseases (Viral Diseases) 10/2023 - 08/2009
5	Carcinoma (Carcinomatosis) 01/2022 - 01/2017
5	Neoplasms (Cancer) 01/2022 - 11/2017
4	Cytomegalovirus Infections (Inclusion Disease) 12/2023 - 01/2019
4	Respiratory Syncytial Virus Infections 01/2020 - 01/2017
4	Congenital Abnormalities (Deformity) 01/2017 - 10/2011
3	Schizophrenia (Dementia Praecox) 08/2021 - 01/2014
3	Paramyxoviridae Infections (Parainfluenza) 10/2017 - 01/2017
2	Inflammation (Inflammations) 05/2024 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
2	Anhedonia 01/2020 - 11/2017
2	Esophageal Neoplasms (Esophageal Cancer) 10/2019 - 11/2017
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2017 - 10/2017
2	Hearing Loss (Hearing Impairment) 11/2004 - 05/2004
2	Deafness (Deaf Mutism) 11/2004 - 05/2004
1	Dyskinesias (Dyskinesia) 03/2024
1	Parkinson Disease (Parkinson's Disease) 03/2024
1	Iron Overload 09/2023
1	Wound Infection (Wound Infections) 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Cross Infection (Nosocomial Infection) 01/2023
1	Genomic Instability 02/2022
1	Carcinogenesis 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Symptom Flare Up 08/2021
1	Hypercalcemia (Milk Alkali Syndrome) 01/2021
1	Lung Injury 01/2020
1	Spontaneous Abortion (Miscarriage) 12/2019
1	Retinoblastoma (Glioblastoma, Retinal) 10/2019
1	Cognitive Dysfunction 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Edema (Dropsy) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 12/2023 - 10/2011
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2004
10	AntibodiesIBA 10/2023 - 02/2002
10	Neutralizing AntibodiesIBA 01/2022 - 10/2011
8	Glycoproteins (Glycoprotein)IBA 10/2023 - 01/2017
7	Monoclonal AntibodiesIBA 10/2023 - 01/2016
5	Cytomegalovirus VaccinesIBA 10/2023 - 05/2014
5	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 02/2002
4	AntigensIBA 11/2020 - 01/2008
4	Connexin 43 (Connexin43)IBA 01/2019 - 01/2017
3	GlobulinsIBA 01/2022 - 06/2015
3	EpitopesIBA 01/2022 - 06/2015
3	CyclinsIBA 10/2019 - 01/2017
3	CytokinesIBA 01/2018 - 07/2007
2	Type III Secretion SystemsIBA 10/2023 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
2	IronIBA 01/2023 - 05/2004
2	LipopolysaccharidesIBA 01/2020 - 01/2008
2	MF59 oil emulsionIBA 01/2020 - 01/2017
2	Cyclin D2IBA 10/2019 - 01/2017
2	Antiviral Agents (Antivirals)IBA 09/2017 - 01/2017
2	Paliperidone Palmitate FDA Link 04/2015 - 01/2014
2	Antipsychotic Agents (Antipsychotics)IBA 04/2015 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 08/2009 - 07/2007
2	12S ribosomal RNAIBA 11/2004 - 05/2004
1	CopperIBA 05/2024
1	OxidesIBA 05/2024
1	Levodopa (L Dopa)FDA LinkGeneric 03/2024
1	Glutamine (L-Glutamine)FDA Link 10/2023
1	Glutathione (Reduced Glutathione)IBA 09/2023
1	HydrogelsIBA 01/2023
1	Doxycycline (Periostat)FDA LinkGeneric 01/2023
1	GalliumIBA 01/2023
1	MetalsIBA 01/2023
1	bicozamycin (FR 1881)IBA 01/2023
1	ArsenicIBA 01/2022
1	Hypochlorous Acid (Hypochlorite)IBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	gallium nitrate FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 11/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020
1	Subunit VaccinesIBA 01/2020
1	Lipid NanoparticlesIBA 01/2020
1	mRNA VaccinesIBA 01/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	Viral AntigensIBA 12/2019
1	MK-1654IBA 12/2019
1	Cyclin D3IBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	Bispecific AntibodiesIBA 01/2018
1	bapineuzumabIBA 01/2018
1	Protein Kinase CIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2018
1	Duration of Therapy 03/2024
1	Transplantation 01/2022
1	Wearable Electronic Devices 08/2021
1	Radiotherapy 05/2020
1	Activities of Daily Living (ADL) 01/2018